“Risk-Based” Enforcement Approach to Homeopathic Products Will Be Taken By Federal Regulators
FDA will only step in with enforcement when homeopathic products constitute a potential health threat, according to new guidance issued this week
FDA will only step in with enforcement when homeopathic products constitute a potential health threat, according to new guidance issued this week